ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,850Medicare Part D Prescriptions Filled, Including Refills

Rank: 164 out of 939

$458K Total Retail Price of All Prescriptions

Rank: 293 out of 939

437 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 437 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 10,764 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
SIMVASTATIN 820 728 1 2
AMLODIPINE BESYLATE 594 505 2 6
HYDROCHLOROTHIAZIDE 499 466 3 12
LEVOTHYROXINE SODIUM 450 344 4 4
FUROSEMIDE 371 336 5 7
OMEPRAZOLE 331 244 6 5
METFORMIN HCL 318 272 7 8
LISINOPRIL 293 253 8 3
WARFARIN SODIUM 279 230 9 17
SERTRALINE HCL 273 210 10 24
GABAPENTIN 262 224 11 11
POTASSIUM CHLORIDE 241 237 12 9
ATORVASTATIN CALCIUM 240 221 13 22
METOPROLOL TARTRATE 238 207 14 10
ALENDRONATE SODIUM 198 198 15 40
ATENOLOL 187 175 16 19
ENALAPRIL MALEATE 183 183 17 65
LISINOPRIL-HYDROCHLOROTHIAZIDE 166 139 18 23
TRAZODONE HCL 161 122 19 26
TRAMADOL HCL 157 101 20 16
ZOLPIDEM TARTRATE 154 123 21 20
PRAVASTATIN SODIUM 130 118 22 13
TAMSULOSIN HCL 112 109 23 27
HYDROCODONE-ACETAMINOPHEN 107 96 S3 24 1
CHLORTHALIDONE 105 88 25 165
DIOVAN 99 73 26 50
CARVEDILOL 99 83 26 25
QUETIAPINE FUMARATE 96 66 28 69
METOPROLOL SUCCINATE 96 87 28 21
GLIPIZIDE ER 89 73 30 88
MELOXICAM 88 61 31 14
DONEPEZIL HCL 87 65 32 30
AMOXICILLIN 85 66 33 92
CITALOPRAM HBR 84 78 34 15
PAROXETINE HCL 81 58 35 70
CEFTRIAXONE 79 70 36 197
DILTIAZEM 24HR CD 74 74 37 126
ACETAMINOPHEN-CODEINE 72 67 S3 38 116
NAMENDA 72 72 38 49
MIRTAZAPINE 71 42 40 56
DILTIAZEM ER 70 70 41 94
DIOVAN HCT 70 58 41 74
RISPERIDONE 69 69 43 82
ESCITALOPRAM OXALATE 69 61 43 61
CLOPIDOGREL 69 62 43 28
KLOR-CON M20 68 64 46 90
GLIMEPIRIDE 66 55 47 37
AZITHROMYCIN 66 53 47 32
NEXIUM 62 43 49 18
LIDOCAINE HCL 61 54 50 223
GEMFIBROZIL 61 39 50 100
CYMBALTA 60 33 52 44
LANTUS 60 44 52 59
FLUTICASONE PROPIONATE 58 48 54 43
PREDNISONE 58 54 54 42
POLYETHYLENE GLYCOL 3350 56 43 56 57
AMITRIPTYLINE HCL 56 45 R 56 38
DIGOXIN 55 43 58 45
LIPITOR 53 51 59 127
GLIPIZIDE 53 53 59 52
PLAVIX 51 46 61 48
SEROQUEL 51 42 61 139
CRESTOR 51 23 61 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.